Abstract:During injury and infection of tissue, inflammation is a response by macrophages and other cell types to effect healing and repair; however, when inflammation becomes dysregulated, it causes a variety of pathologies. In macrophages, there is a lack of detailed information on the cell signaling kinetics that regulate the response of pro‐inflammatory mediator TNFα to lipopolysaccharide (LPS), which could guide the use of anti‐inflammatory drugs without affecting the normal reparative process. To address this gap, we used cultured RAW 264.7 (RAW) macrophage cells and set out to define intracellular signaling kinetics, mRNA expression, and cytokine production in cells treated with 10 ng/mL LPS over a 24‐hr period and in parallel vehicle‐treated cells All results except protein secretion are expressed relative to 15‐min vehicle control (P <0.05). We first measured the expression level of IκBα since it acts as a negative feedback to inhibit transcription factor NFκB activity by sequestering it in the cytoplasm. LPS stimulates IκBα degradation, releasing NFκB that translocates to the nucleus and regulates IκBα and TNFα expression. In cytoplasmic lysates, the abundance of IκBα was reduced by 78% 45‐min following LPS treatment, but began to increase at 10‐hr, reaching a maximum at 16 hr (2.4‐fold) and decreasing at 24‐hr. Transcription factor p65 NFκB governs cytokine expression, so we also measured its activation by assessing Serine 536 phosphorylation, nuclear translocation, and binding to DNA consensus sequences. NFκB phosphorylation in cytoplasmic lysates was significantly increased 45‐min following LPS treatment, was maximal at 2‐hr (3.8‐fold), and decreased to basal levels by 6‐hr. The abundance of NFκB in nuclear lysates was elevated 30‐min following LPS treatment, was maximal by 45‐min (2.6‐fold), and returned to basal levels by 24‐hr. Binding of nuclear NFκB to consensus oligonucleotide sequences in nuclear lysates followed a similar pattern to that observed for p‐NFκB. Finally, we measured expression of LPS‐stimulated inflammatory mediator TNFα and its negative feedback regulator IL‐10. Following LPS treatment, TNFα mRNA expression began at 1‐hr, was maximal at 6‐hr (18‐fold), and decreased starting at 10‐hr but remained significantly elevated up to 24‐hr. TNFα protein secretion in conditioned growth medium began at 4‐hr and accumulated to a maximal concentration by 16 hr (9.8 ng/mL). IL‐10 mRNA expression was induced by LPS at 10‐hr, was maximal at 16 hr (530‐fold), and remained elevated at 24 hr. IL‐10 protein secretion was induced at 16‐hr and continued to accumulate to a maximal concentration at 24‐hr (620 pg/mL). These data provide a foundation that could aid in identifying pharmacological targets that control the inflammatory process in tissues. The views expressed in this abstract are those of the authors and do not reflect the official policy of the Department of Army, Department of Defense, or the U.S. Government. This abstract has been approved for public release with unlimited distribution.

Tonic TNF conditioning of macrophages safeguards stimulus‐specific inflammatory responses

TNF Activates an IRF1-dependent Autocrine Loop Leading to Sustained Expression of Chemokines and STAT1-dependent Type I Interferon–response Genes

Regulation of Tnf Expression by Multiple Mitogen-Activated Protein Kinase Pathways

IL-10 dependent adaptation allows macrophages to adjust inflammatory responses to TLR4 stimulation history

Gene-selective transcription promotes the inhibition of tissue reparative macrophages by TNF

NF-κB Signaling and Cell-Fate Decision Induced by a Fast-Dissociating Tumor Necrosis Factor Mutant.

Identification of two forms of TNF tolerance in human monocytes: differential inhibition of NF-κB/AP-1- and PP1-associated signaling

14-3-3 Epsilon Dynamically Interacts with Key Components of Mitogen-Activated Protein Kinase Signal Module for Selective Modulation of the Tnf-Alpha-Induced Time Course-Dependent Nf-Kappa B Activity

Distinct and Nonredundant in Vivo Functions of TNF Produced by T Cells and Macrophages/neutrophils: Protective and Deleterious Effects.

MicroRNAs Modulate the Noncanonical Transcription Factor NF-κB Pathway by Regulating Expression of the Kinase IKKα During Macrophage Differentiation

Protective role of tumor necrosis factor (TNF) receptors in chronic intestinal inflammation: TNFR1 ablation boosts systemic inflammatory response

TNF is a homoeostatic regulator of distinct epigenetically primed human osteoclast precursors

NFkB activation and cytokine output in LPS‐treated RAW 264.7 macrophages

Attenuated EAN in TNF-α Deficient Mice is Associated with an Altered Balance of M1/M2 Macrophages

TNF, Cell Death and Inflammation

NF-κB signalling and cell fate decisions in response to a short pulse of tumour necrosis factor

Apoptotic, non-apoptotic, and anti-apoptotic pathways of tumor necrosis factor signalling

TET1 is an Important Transcriptional Activator of TNFα Expression in Macrophages

Tumor necrosis factor induces GSK3 kinase–mediated cross-tolerance to endotoxin in macrophages

Apoptotic Cells and Innate Immune Stimuli Combine to Regulate Macrophage Cytokine Secretion

Unfolded Protein Response Differentially Regulates TLR4-Induced Cytokine Expression in Distinct Macrophage Populations